Because leukemia is a blood cancer, it can affect a person’s platelet count. People with leukemia sometimes have a low platelet count. However, other conditions can also cause low platelets. Leukemia ...

An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...

Crucially, for thrombocytopenia questions, technicians must recognize that automated counters can sometimes misinterpret large platelets or clumps, making the manual smear review and AI-assisted ...

Neonatal alloimmune thrombocytopenia (NAIT) is a disorder that affects pregnant people and their fetuses. It occurs when the birthing parent’s immune system produces antibodies that attack and destroy ...

Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence. The ...

Thrombocytopenia occurs when there aren’t enough platelets, which are tiny blood cells that help with clotting. In some cases, thrombocytopenia is the first sign of acute HIV infection. Severe ...

Abstract and Introduction Review of Normal Platelet Physiology and Megakaryocytopoisis Qualitative Platelet Abnormalities Conclusion References Nitric oxide (NO) is another drug used in the neonatal ...

The anti-CD38 monoclonal antibody mezagitamab had similar safety to placebo in patients with persistent or chronic immune thrombocytopenia. The drug also significantly increased platelet counts, a key ...

Takeda may have pruned back the potential indications for mezagitamab, but the latest raft of phase 2 data suggests the anti-CD38 antibody could still “transform treatment” of primary immune ...